ArticleFrontiers in medicine2025

The STAT3/TIMP1 inhibitor silibinin overcomes secondary immunoresistance to pembrolizumab in brain metastases from METex14 skipping mutated non-small cell lung cancer: a case report.

Joaquim Bosch-Barrera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.